Cresco Labs (CRLBF) Other Working Capital Changes (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Other Working Capital Changes came in at -$2.3 million in Q1 2026, up 14.93% YoY from -$2.0 million in Q1 2025, and up 74.44% on a QoQ basis from -$9.0 million in Q4 2025.
Cresco Labs (CRLBF) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Other Working Capital Changes data on file, last reported at -$2.3 million in Q1 2026.
- Quarterly Other Working Capital Changes rose 14.93% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.1 million (up 12.35% YoY) and the FY2025 annual result came in at -$9.5 million, down 19.68% from the prior year.
- Other Working Capital Changes advanced to -$2.3 million in Q1 2026, from -$9.0 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $12.3 million in Q4 2025 to a low of -$6.1 million in Q2 2022.
- A 5-year average of -$447411.8 and a median of $119000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes tumbled 4739.66% — and 2025, when it soared 1292.36%.
- Tracing CRLBF's Other Working Capital Changes over 5 years: stood at $774000.0 in 2022, then plunged by 4739.66% to -$35.9 million in 2023, then jumped by 76.47% to -$8.4 million in 2024, then declined by 6.05% to -$9.0 million in 2025, then jumped by 74.44% to -$2.3 million in 2026.
- The last three Other Working Capital Changes figures came in at -$2.3 million (Q1 2026), -$9.0 million (Q4 2025), and $190000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.79 Mn |
| Mar 31, 2026 | -5.79 Mn |
| Mar 31, 2026 | -5.79 Mn |
| Dec 31, 2025 | 12.30 Mn |
| Dec 31, 2025 | 12.30 Mn |
| Dec 31, 2025 | 12.30 Mn |
| Sep 30, 2025 | 822,000.00 |
| Sep 30, 2025 | 822,000.00 |
| Sep 30, 2025 | 822,000.00 |
| Jun 30, 2025 | -1.22 Mn |
| Jun 30, 2025 | -1.22 Mn |
| Jun 30, 2025 | -1.22 Mn |
| Mar 31, 2025 | -4.11 Mn |
| Mar 31, 2025 | -4.11 Mn |
| Mar 31, 2025 | -4.11 Mn |
| Dec 31, 2024 | -2.68 Mn |
| Dec 31, 2024 | -2.68 Mn |
| Dec 31, 2024 | -2.68 Mn |
| Sep 30, 2024 | 119,000.00 |
| Sep 30, 2024 | 119,000.00 |